Question Title

* 1. Please indicate how well the program's learning objectives were met by applying the following scale:

  Before After
Please rate your level of knowledge to examine data from clinical trials and late-breakers presented at ACC.17
Please rate your level of knowledge to describe how this new data could impact Canadian clinical practice
Please rate your level of knowledge to evaluate how these studies could lead to new treatments and standards of care

Question Title

* 2. Please indicate whether the information presented by the expert was clear and effective:

  Poor Fair Good Very Good Excellent
Dr. Shaun Goodman
Dr. Atul Verma
Dr. Marc S. Sabatine

Question Title

* 3. Did the presenter make a disclosure statement?

  Yes No Not sure
Dr. Shaun Goodman
Dr. Atul Verma
Dr. Marc S. Sabatine

Question Title

* 4. Did you perceive any degree of bias in any part of the presentation?

  Yes No
Dr. Shaun Goodman
Dr. Atul Verma
Dr. Marc S. Sabatine

Question Title

* 5. Additional questions:

Please indicate your response to the questions below by applying the following scale:

  Strongly Disagree Disagree Neutral Agree Strongly Agree
The program met my educational expectations
This program allowed adequate time for interaction (minimum 25% of session)
The subject was relevant to my practice
The overall format was effective for learning

Question Title

* 6. From what you have learned, what will you be able to apply to your practice? What potential barriers do you anticipate and how will you overcome them?

Question Title

* 7. Please indicate which topics related to this program and therapeutic area that you would like to hear more about in the future:

Question Title

* 8. How did you hear about Breaking News from ACC.17 iMedicus?

Question Title

* 9. Did this event adhere to CMA guidelines governing the relationship between physicians and industry?

Question Title

* 10. Additional comments:

T